ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Noxafil, Suspension zum Einnehmen - 105 ml
57843001 MSD Merck Sharp & Dohme AG
Noxafil, Suspension zum Einnehmen02.03.2007
Original02.03.2007
Posaconazole (J02AC04) 
WHO-DDD 
08.06.105 ml
08.06. 
B  
Yes 
IPCI
564.45Yes
    
10 %627.15
7680578430015Synthetika
3458314 
Composition
posaconazolum 40 mg, polysorbatum 80, glucosum liquidum, arom.: vanillinum et alia, conserv.: E 211, alcohol benzylicus, excipiens ad suspensionem pro 1 ml.
Packungsbestandteile
Suspension (oral) 
  
 
Active AgentDose
Posaconazole40 mg
BAG: Active AgentDose
Posaconazole40 mg
 
Inactive agents additional_information
Alcohol Benzylicus  
Alia  
E 211 conserv.
Glucosum Liquidum  
Polysorbatum 80  
Vanilline arom.
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home